Shields, MD, L. B. E., Johnson, BS, T. A., Daniels, MS, M. W., Bell, MSN, RN, CPN, A., Siemens, PharmD, D. M., Jennings, MD, MBA, J. T., Hester, MD, MBA, S. T., & Honaker, MD, MBA, FAAP, J. T. (2021). Reduction in Schedule II opioid prescribing by primary care providers, orthopedic and general surgeons, and pain management specialists following the implementation of a State House Bill and an Institutional Controlled Substance Task Force. Journal of Opioid Management, 17(2), 155–167. https://doi.org/10.5055/jom.2021.0625